U.S-based Novavax (Nasdaq: NVAX) reports today that its COVID-19 vaccine candidate called NVX-CoV2373 or “Coronavax” demonstrated 100% protection against moderate and severe disease and 90.4%…
Apparently, Congressman Sen Ron Johnson (R-Wis) is in hot water again with social media, this time his team uploaded a video associated with a June…
While TrialSite frequently follows clinical investigational superstars and their breakthroughs around the world, just as important are those practicing physicians in the clinic, in the…
Dr. Ron Brown June 13, 2021 Social distancing and lockdowns may come with an extra harmful risk of suicide attempts for young girls. In an…
Principal Investigators’ pathway to positive prominence and status associated with path-breaking research can lead to many positive outcomes, from talent and potential branding for the…
A June 8 article from the University of Sydney takes us to the southeastern Australian State of New South Wales (NSW), where experts have gotten…
China’s proclivity toward a nasal-spray vaccine has been present since the onset of the pandemic, since the infections starting spreading in and around Wuhan, China. One…
Researchers from a number of prominent institutions sought to answer the question: what, if anything, does diet have to do with the fact that when…
A team of researchers from Japan, America, and the United Kingdom recently launched a study to develop therapeutics attacking SARS-CoV-2, the virus behind COVID-19, in…
A $10 million national grant from Singapore supports a global research collaborative effort targeting the challenges associated with glioblastoma, a highly aggressive and deadly type…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
